$0.77
-0.03 (-3.79%)
Open$0.83
Previous Close$0.80
Day High$0.83
Day Low$0.73
52W High$3.13
52W Low$0.53
Volume—
Avg Volume270.5K
Market Cap99.90M
P/E Ratio—
EPS$-5.24
SectorN/A
Analyst Ratings
Buy
9 analysts
Price Target
+412.5% upside
Current
$0.77
$0.77
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.39B | 1.27B | 17.89M |
| Net Income | -551,987,966 | -453,937,472 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -414,832,375 | -360,097,547 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.66 | -0.60% | — | 4.19B |
| PICS | Pics Nv | $10.63 | -0.09% | 6.1 | 1.37B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.40% | 74.6 | 640.19M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.67 | -0.19% | 35.3 | 334.79M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.10% | 57.5 | 591.76M |